A series of factors will contribute to the overall value proposition in those settings, which include the prevalence of G6PD deficiency in the local population served, the likelihood that a G6PD-deficient individual will suffer associated pathologies later in life and the ability for the test result at birth to be associated with the individual throughout their life. The gene discussed is G6PD; the disease is G6PD deficiency.